Recombinant thrombopoietin effectively shortens the time to response and increases platelet counts in elderly patients with severe immune thrombocytopenia

HIGHLIGHTS

  • who: Yang Li et al. from the Department of Hematology, Zhongshan Hospital, Qingpu Branch, Fudan University, Gong Yuan Dong Road, Shanghai, China have published the Article: Recombinant Thrombopoietin Effectively Shortens the Time to Response and Increases Platelet Counts in Elderly Patients with Severe Immune Thrombocytopenia, in the Journal: (JOURNAL) of 13/08/2022
  • what: Background: This study was conducted to investigate the short-term efficacy and safety of rhTPO for the management of ITP in the elderly as first-line treatment. For life-threatening bleeding events, which are quite frequent in severe ITP, the major . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?